ERGIC2
Endoplasmic reticulum-Golgi intermediate compartment protein 2
Also known as: ERGI2_HUMAN, Erv41, PTX1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96RQ1
- Gene
- ERGIC2
- Ensembl
- ENSG00000087502
- Chromosome
- 12
- Canonical length
- 377 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli rim,Golgi apparatus,Vesicles
OverviewNCBI Gene
ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).[supplied by OMIM, Aug 2008]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>Q96RQ1|ERGIC2
1 MRRLNRKKTL SLVKELDAFP KVPESYVETS ASGGTVSLIA FTTMALLTIM EFSVYQDTWM
61 KYEYEVDKDF SSKLRINIDI TVAMKCQYVG ADVLDLAETM VASADGLVYE PTVFDLSPQQ
121 KEWQRMLQLI QSRLQEEHSL QDVIFKSAFK STSTALPPRE DDSSQSPNAC RIHGHLYVNK
181 VAGNFHITVG KAIPHPRGHA HLAALVNHES YNFSHRIDHL SFGELVPAII NPLDGTEKIA
241 IDHNQMFQYF ITVVPTKLHT YKISADTHQF SVTERERIIN HAAGSHGVSG IFMKYDLSSL
301 MVTVTEEHMP FWQFFVRLCG IVGGIFSTTG MLHGIGKFIV EIICCRFRLG SYKPVNSVPF
361 EDGHTDNHLP LLENNTHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERGIC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- testis: 54 nTPM
- placenta: 50 nTPM
- heart muscle: 49 nTPM
- epididymis: 47 nTPM
- urinary bladder: 47 nTPM
- salivary gland: 46 nTPM
Single-cell type
- early spermatids: 393 nCPM
- late primary spermatocytes: 282 nCPM
- esophageal apical cells: 229 nCPM
- plasma cells: 207 nCPM
- syncytiotrophoblasts: 189 nCPM
- esophageal suprabasal cells: 163 nCPM
Immune cell
- neutrophil: 185 nTPM
- T-reg: 132 nTPM
- plasmacytoid DC: 121 nTPM
- memory CD4 T-cell: 108 nTPM
- naive CD4 T-cell: 107 nTPM
- MAIT T-cell: 103 nTPM
Brain region
- white matter: 57 nTPM
- hypothalamus: 41 nTPM
- spinal cord: 40 nTPM
- medulla oblongata: 40 nTPM
- cerebellum: 39 nTPM
- cerebral cortex: 38 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ERGIC2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 62 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.07
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum to Golgi vesicle-mediated transport
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ERGIC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERGIC2 as an antibody target. Whether an autoantibody or antibody against ERGIC2 could matter depends on whether native ERGIC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERGIC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ERGIC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...